2 Feldman HA,Goldstein I, Hatzichristou D et al. Impotence and its medical and psycholocial correlates:results of the Massachusetts Male Aging Study[J]. J Urol， 1994，151(1):54～61.
3 NIH Consensus Conference. Impotence.NIH Consensus Development Panel on Impotence[J].JAMA， 1993,270(1): 83～90.
4 Rajfer J,Aronson WJ,Bush PA et al.Nitric oxide as a mediator of relaxation ofthe corpus cavernosum in response to nonadrenergic,noncholilnergic neurotransmission[J].N Engl J Med， 1992,326:90～94.
5 Boolell M,Gep-iAttee S,Gingell JC et al.Sildenafil,a novel effective oraltherapy for male erectile dysfunction[J].Br J Urol， 1996,78（2）：257～261.
6 Goldstein I,Lue TF,Padma-Nathan H et al.Oral sildenafil in the treatment oferectile dysfunction[J].N Engl J Med， 1998,338:1397～1404.
7 Hultling C.Partners perceptions of efficacy of sildenafil in the treatment oferectile dysfunction[J].Int J Impot Res， 1998,10(suppl 3):S32.
8 Steers WD. META-Analysis of the efficacy of sildenafil in the treatment ofsevere erectile dysfunction[J].J Urol， 1998,159(suppl):238.
2000-06-02
2000-07-20
9Akmal Taher.Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors[J].World Journal of Urology.2004(6)
7Kim SW,Lee WC,Kim MT,et al.Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Korean J Urol,2013,54(10):697-702.
8Kaplan SA.Re:Preservation of sexual function with the prostatic urethral lift:a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.J Urol,2013,190(4):1342.
10Nickel JC,Shoskes DA.Phenotypic approach to the management of the chronic prostatitischronic pelvic pain syndrome.Bju International,2010,106(9):1252-1263.
